Home › NDC Lookup › RxCUI directory › RxCUI 1596778

14 ACTUAT budesonide 2 MG/ACTUAT Rectal Foam [Uceris] — RxCUI 1596778

RxNorm drug concept · Semantic branded drug
RxCUI 1596778 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1596778
Official name14 ACTUAT budesonide 2 MG/ACTUAT Rectal Foam [Uceris]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asUceris 2 MG/ACTUAT Rectal Foam, 14 ACTUAT
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)11 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Budesonide Nasal Spray: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • You might notice some improvement on the very first day, but don't give up if you don't feel a big difference right away. The full benefit from this spray usually builds up over ab...
  • How long does it take for budesonide nasal spray to actually work?
  • Children 6 and older can use budesonide nasal spray, but an adult should supervise use for kids ages 6 to under 12. The spray should not be used in children under 6. One thing to k...
  • Can my child use this spray, and is it safe for long-term use in kids?
📖 Read our full Budesonide Nasal Spray guide →

🕸️ Concept Web — How 14 ACTUAT budesonide 2 MG/ACTUAT Rectal Foam [Uc... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 14 ACTUAT budesonide 2 MG/ACTUAT Rectal Foam [Uceris] RxCUI 1596778

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Budesonide 19831
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Uceris 1366551
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Budesonide Rectal Foam 1596772
    • Budesonide Rectal Product 1151340
    • Budesonide Rectal Foam [Uceris] 1596775
    • Uceris Rectal Product 1596776
    • Rectal Foam 317542
    • Rectal Product 1151127
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Budesonide 2 MG/ACTUAT [Uceris] SBDC · 1596774
  • Budesonide Rectal Foam [Uceris] SBDF · 1596775
  • Uceris Rectal Product SBDG · 1596776
  • Uceris BN · 1366551

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1596778 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
65649-0651-03 2 CANISTER in 1 CARTON (65649-651-03) / 1 AEROSOL, FOAM in... Uceris Salix Pharmaceuticals, Inc. 2014-12-01
Observed labelers: Salix Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.